1. Home
  2. NVR vs TEVA Comparison

NVR vs TEVA Comparison

Compare NVR & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVR Inc.

NVR

NVR Inc.

HOLD

Current Price

$7,508.92

Market Cap

20.5B

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$28.38

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVR
TEVA
Founded
1980
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NVR
TEVA
Price
$7,508.92
$28.38
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$8,366.67
$27.00
AVG Volume (30 Days)
20.7K
11.4M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
456.53
0.62
Revenue
$10,582,633,000.00
$16,776,000,000.00
Revenue This Year
N/A
$4.74
Revenue Next Year
N/A
$0.48
P/E Ratio
$16.51
$46.12
Revenue Growth
2.93
0.02
52 Week Low
$6,562.85
$12.47
52 Week High
$9,143.28
$28.68

Technical Indicators

Market Signals
Indicator
NVR
TEVA
Relative Strength Index (RSI) 54.05 80.93
Support Level $7,450.00 $24.01
Resistance Level $7,746.79 $26.96
Average True Range (ATR) 142.52 0.68
MACD 46.78 0.19
Stochastic Oscillator 69.77 94.65

Price Performance

Historical Comparison
NVR
TEVA

About NVR NVR Inc.

NVR Inc is a United States-based homebuilding company. It builds single-family detached homes, townhomes, and condominium buildings under three brands, Ryan Homes, NVHomes, and Heartland Homes. The company through its subsidiary also operates a mortgage banking and title services business. The homebuilding segment includes four geographic areas of the Mid-Atlantic, North East, Mid-East, and South East.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: